Streetbeat News

Equity Actions

TASK

Analysts have mixed views on TaskUs (NASDAQ:TASK), with ratings ranging from bullish to bearish over the last quarter. The average 12-month price target has increased to $14.25, up 6.9% from $13.33. Recent analyst actions include ratings and price target adjustments by Guggenheim, RBC Capital, B of A Securities, and Citigroup. TaskUs's financials show a decline in revenue growth, but strong net margin, ROE, and ROA, with a debt-to-equity ratio below industry norms.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 2:01 pm

ALPN

Six financial analysts have recently provided ratings on Alpine Immune Sciences (NASDAQ:ALPN), with a mix of bullish and somewhat bullish perspectives. The average 12-month price target for ALPN is now $41.5, marking a significant increase from the previous average of $27.40. This adjustment reflects a positive sentiment shift among analysts, with recent actions including rating upgrades and price target raises by firms such as Wedbush, Oppenheimer, HC Wainwright & Co., and RBC Capital. Alpine Immune Sciences, a clinical-stage biopharmaceutical company, has shown a revenue growth rate of 20.03% as of September 30, 2023, but faces challenges in net margin, ROE, and ROA, despite a strong market capitalization and sound debt management.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 2:01 pm

DAVA

Analyst ratings for Endava (NYSE:DAVA) show a mix of bullish to bearish sentiments, with recent actions including ratings adjustments and changes in price targets. The average 12-month price target is now $62.08, down 19.03% from the previous $76.67. Endava faces challenges in revenue growth, net margin, ROE, and ROA, indicating potential difficulties in maintaining profitability and operational efficiency.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 2:00 pm

FOUR

Shift4 Payments (NYSE:FOUR) has received diverse analyst ratings over the last three months, with a current average 12-month price target of $91.17, up 14.43% from the previous $79.67. Analyst actions include maintaining, raising, and lowering ratings and price targets, reflecting evolving market conditions and company performance. Shift4 Payments exhibits lower market capitalization, notable revenue growth of 31.19% as of December 31, 2023, but faces challenges in profitability, asset utilization, and higher financial risk due to a debt-to-equity ratio of 2.72.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 2:00 pm

BYND

Beyond Meat Inc (NASDAQ:BYND) shares are trading lower after announcing a mixed securities shelf offering of up to $250 million. The offering may include various securities types. Beyond Meat reported $205.9 million in cash and equivalents and $1.1 billion in debt as of Dec. 31. The stock has underperformed the broader market, down about 45% over a year and 48.98% year to date, but has outperformed its historical average annual return of -60.93%. The current RSI is 49.6, indicating neutral conditions.

Portfolio Pulse from Adam Eckert

March 19, 2024 | 1:23 pm

BYND

Beyond Meat's stock price is trading lower following the company's announcement of a mixed securities shelf offering.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 1:23 pm

NCMI

National CineMedia, Inc. (NASDAQ:NCMI) shares surged after reporting Q4 financial results that exceeded expectations and announcing a $100 million share repurchase program. The company's operating revenue was $90.9 million, surpassing the consensus of $81.1 million. National advertising revenue grew 2% Y/Y, while local and regional advertising revenue declined 5% Y/Y. Operating income and adjusted OIBDA decreased due to increased amortization expenses. EPS was $0.24, beating the consensus of $0.09. For Q1 2024, NCM expects revenue between $34.5 million and $35.5 million and an adjusted OIBDA loss of $(7.5) million to $(6.5) million. The share repurchase program is authorized through April 1, 2027, and NCMI shares are up 20.85% at $5.10 in premarket trading.

Portfolio Pulse from Lekha Gupta

March 19, 2024 | 1:18 pm

BTCUSD

ETHUSD

SPY

Cryptocurrencies like Bitcoin, Ethereum, and Dogecoin are trading mixed amid a wider market correction, with predictions of Bitcoin rallying to $160K. In the US market, DLocal reported mixed Q4 results, joining other stocks moving lower. Global and US political developments include discussions on property seizures, social media censorship, and international tensions. The US and world economy show signs of strength and challenges, with rate changes and legal issues for companies like Evergrande. In tech, AI's impact on companies like Apple, Nvidia, and Tesla is highlighted, alongside discussions on electric vehicles and cybersecurity collaborations. Consumer, communication, industrial, and healthcare sectors also saw significant news.

Portfolio Pulse from Akanksha Bakshi

March 19, 2024 | 1:17 pm

PIXY

ShiftPixy shares are trading lower following the announcement of a $5 million offering priced at-the-market.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 1:12 pm

ELVN

Enliven Therapeutics' stock is trading higher following the announcement of a $90 million private placement financing and updates on its pipeline.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 1:10 pm